โจทย์ ปรนัย
Which of the following best describes the concept of "beat perception" as it relates to the auditory capabilities of newborn infants?

The article defined beat perception as the ability to detect temporal periodicity in sound sequences or a regular pulse, which is distinct from statistical learning. Newborns demonstrated this by showing neural responses to deviants in isochronous sequences but not in jittered sequences, indicating sensitivity to rhythmic regularity.

Abstract: "Beat perception" is described as extracting periodicity in the input, referred to as a "regular pulse or the 'beat'" Introduction: "Temporal structure in rhythm often comes in the form of a regular beat: a series of perceived regularly recurring salient events"

โจทย์ ปรนัย
According to the research, what experimental method is used to differentiate beat perception from statistical learning in newborns?

The article stated that the study used EEG in order to measure newborn infants' brain responses to auditory stimuli in two conditions: isochronous (regular timing) and jittered (irregular timing) sequences.

Abstract: "Here, we manipulated the isochrony of sound sequences in order to disentangle statistical learning from beat perception in sleeping newborn infants in an EEG experiment, as previously done in adults and macaque monkeys." Methods: "EEG was recorded with Ag/AgCl electrodes attached to the Fp1, Fp2, Fz, F3, F4, F7, F8, T3, T4, Cz, C3, C4, Pz, P3, P4 locations according to the International 10–20 system... Data was recorded using a direct-coupled amplifier (V-Amp, Brain Products, Munich, Germany) at 24-bit resolution with a sampling rate of 1000 Hz."

โจทย์ ปรนัย
What does the mismatch response (MMR) in EEG studies indicate about newborns' auditory processing?

The article defined the mismatch response (MMR) as an EEG component that reflects the newborns' ability to detect deviations from expected auditory patterns, indicating sensitivity to violations of temporal or sequential regularities, demonstrated by stronger MMR responses to deviants in isochronous sequences compared to jittered ones.

Abstract: "We compared mismatch responses to infrequent deviants falling on either accented or unaccented positions. Results showed a clear difference between metrical positions in the isochronous sequence, but not in the jittered sequence." Introduction: "The mismatch response (MMR)... can be measured in young infants in response to regularity violations." Discussion: "The dependence of difference responses on metrical position in the isochronous, but not the jittered condition is indicative of the presence of beat processing."

โจทย์ ปรนัย
What does the term "statistical learning" refer to in the context of auditory processing in newborns?

The article defined statistical learning in newborns as the ability to extract patterns from sound sequences automatically without conscious effort or external reinforcement. This is distinguished from beat perception and other auditory capabilities.

Abstract: "Statistical learning in its narrowest sense is the extraction of these regularities from the order of the elements of the input without explicit feedback or even awareness after prolonged exposure." Introduction: "Statistical learning is thought to be a domain general mechanism manifest in different domains, including audition... There is evidence that statistical learning is already functional at birth." Discussion: "Here, since we examine newborn responses, we consider beat detection to be evident from brain responses even in the absence of overt behavior... statistical learning by itself does not fully explain beat processing."

โจทย์ ปรนัย
Which condition in the EEG study did NOT result in a differentiation between beat and offbeat responses in newborns?

The article clearly showed that the newborns only demonstrated different neural responses to beat versus offbeat positions in the isochronous condition, not in the jittered condition.

Abstract: "Results showed a clear difference between metrical positions in the isochronous sequence, but not in the equivalent jittered sequence." Results: "Planned comparisons revealed that MMR amplitudes were significantly more negative for Beat responses, compared to Offbeat responses in the Isochronous Timing condition whereas they did not differ from each other in the Jittered Timing condition." Discussion: "The dependence of difference responses on metrical position in the isochronous, but not the jittered condition is indicative of the presence of beat processing."

โจทย์ ปรนัย
Which neural mechanism is thought to underlie the synchronization of movement to a beat?

The article identified neural entrainment as the key mechanism that enables synchronization to a beat, where internal brain oscillations align with external rhythmic stimuli. This is presented as a fundamental process distinct from other neural mechanisms.

Introduction: "This coordination is thought to result from the coupling of internal low frequency oscillations in auditory and motor areas with the external rhythmic signal (neural entrainment)." Discussion: "The ability to synchronize and coordinate movement with a regular beat is called rhythmic entrainment... Beat-based timing has been suggested to be somewhat separate from other timing processes."

โจทย์ ปรนัย
How does beat perception in newborns relate to their later musical abilities?

The article established that beat perception is a foundational biological capacity that enables basic musicality, particularly rhythmic processing.

Introduction: "Beat processing (or beat perception) has been argued to be a fundamental component of the capacity for music and a prerequisite for being able to dance and make music together." Discussion: "Beat perception has been suggested to be somewhat separate from other timing processes... This can be considered a biological trait."

โจทย์ ปรนัย
What is the primary purpose of using EEG in studies of auditory processing in newborns?

The article especially stated that EEG was used to measure newborns' neural responses to auditory stimuli, which reveals their ability to process rhythmic patterns and detect deviations in sound sequences.

Abstract: "Here, we manipulated the isochrony of sound sequences... in sleeping newborn infants in an EEG experiment... We compared mismatch responses to infrequent deviants." Methods: "EEG was recorded... Signals were off-line filtered... and epochs of −100–500 ms with respect to sound onset were extracted for each of the D1, D2, S1... stimuli."

โจทย์ ปรนัย
What does an isochronous condition in an auditory study typically involve?

The article defined isochronous sequences as having perfectly regular timing between sounds, which is crucial for inducing beat perception. This contrasts with jittered conditions, where intervals vary randomly.

Abstract:"We used a binary accented sequence that induces a beat when presented with isochronous timing... Sequences in the isochronous condition had an inter-onset interval (IOI) of 225 ms." Methods:"In the isochronous condition, sounds are presented with a constant inter-onset interval (IOI), allowing a beat to be induced." Stimuli Description:"Sequences in the isochronous condition had an inter-onset interval (IOI) of 225 ms, in the jittered condition these were randomly chosen from the range 150 to 300 ms."

โจทย์ ปรนัย
Which auditory feature is NOT directly studied in the newborn auditory processing research?

The article focused exclusively on non-linguistic auditory processing (beat perception, statistical learning, and rhythmic entrainment) without examining language-related abilities. Melody recognition is also not directly studied, but language comprehension is the most clearly excluded feature.

Abstract: "The current study aims to disentangle beat perception from statistical learning in neonates... using non-linguistic auditory stimuli." Introduction: "While both the processing of temporal (beat perception) and statistical regularities have been suggested to be present in neonates, the relationship between these remains unclear." Stimuli Description: "The sounds were made with QuickTime's drum timbres... no speech or linguistic stimuli were used."

โจทย์ ปรนัย
What term is used to describe the appearance of scientific credibility used in the marketing of unproven cell-based therapies?

The article defined tokens of scientific legitimacy as marketing tactics used to falsely portray unproven cell and gene therapies (CGTs) as scientifically credible. These include referencing unrelated research, claiming institutional approvals, or misusing clinical trial registries.

Introduction: "These marketing strategies are collectively referred to as 'tokens of scientific legitimacy'... Their widespread use in direct-to-consumer advertising makes it more difficult for patients to assess if these interventions are appropriate." Features of Unproven Interventions: "Businesses use 'tokens of scientific legitimacy'... to make unproven products seem science-based, subject to appropriate oversight, and ready for clinical deployment."

โจทย์ ปรนัย
According to the article, which of the following is NOT a recognized reporting mechanism for adverse effects from cell and gene therapies?

The article listed specific reporting mechanisms for adverse effects from cell and gene therapies, including MedWatch (FDA), EudraVigilance (EMA), and TGA's safety reporting portal. However, it does not mention Consumer Protection Agencies as a recognized reporting mechanism for adverse effects in this context.

Reporting Mechanisms in the United States and Worldwide: "Examples of such reporting pathways include the following: a) The US FDA has a program called MedWatch... b) The EMA has... EudraVigilance... c) Health Canada provides a consumer reporting portal... d) Australia’s Therapeutic Goods Administration uses reporting portals..."

โจทย์ ปรนัย
What ethical consideration is primarily challenged by direct-to-consumer marketing of unproven cell and gene therapies?

The article highlighted that direct-to-consumer marketing of unproven cell and gene therapies often undermines proper informed consent. Patients may receive inadequate information about risks, lack of proven efficacy, or the experimental nature of these interventions, which in turn violates ethical standards for patient autonomy and decision-making.

Features of Unproven Interventions: "Unproven cell-based interventions typically meet some or all of the following criteria:... inadequate information disclosed to patients to enable proper informed consent." Reporting Mechanisms in the United States and Worldwide: "Written consent documents may not be provided to the recipients of unproven CGTs and, as noted, the use of misrepresentations is rampant in unproven CGTs."

โจทย์ ปรนัย
What key feature differentiates proven CGT products from unproven ones according to regulatory standards?

The article clearly stated that the key regulatory distinction between proven and unproven CGT products is whether they have received formal authorization from recognized regulatory agencies after demonstrating safety and efficacy through rigorous clinical trials.

Introduction: "Approved and proven CGT products, where benefits are determined to exceed risks, are also usually eligible for reimbursement by health insurance providers... pay-to-participate studies that do not meet these criteria... may be signs of concerning/unconventional clinical practice." Approved and Proven CGT Products: "CGT products must undergo a rigorous process of quality, safety and efficacy demonstration under the oversight of regulatory agencies authorized by law to evaluate and approve drugs, biologics and medical devices... Once a CGT product has been shown to be safe and effective, it can receive marketing authorization by the respective regulatory agency."

โจทย์ ปรนัย
Which of the following is a risk associated with unproven CGT products highlighted in the article?

The article explicitly warned that unproven CGT products pose significant health dangers to patients, including severe physical harm and even death, due to their untested nature and lack of regulatory oversight.

Introduction: "This phenomenon persists today, with a global marketplace of clinics selling putative advanced medicinal therapies without substantive evidence of safety and/or efficacy." Features of Unproven Interventions: "These interventions are potentially unsafe and there is little or no evidence to support claims that they will have meaningful therapeutic effects."

โจทย์ ปรนัย
Which of the following is NOT a typical characteristic of unproven CGT products as discussed in the article?

The article clearly states that unproven CGT products are defined by their lack of regulatory approval, making this the characteristic that doesn't apply to them. All other options are explicitly listed as red flags for unproven therapies in the text.

Features of Unproven Interventions: "Unproven cell-based interventions typically meet some or all of the following criteria: - unclear scientific rationale to suggest potential efficacy - lack of understanding on the mechanism of action - insufficient data from in vitro assays, animal models and/or clinical studies - supervision, review and approval by competent government organizations is lacking - payment, often of exorbitant fees, for experimental treatments" Approved and Proven CGT Products: "Approved and proven CGT products are marketed after their quality, safety and effectiveness have been demonstrated through carefully conducted and monitored clinical testing under oversight of regulatory agencies."

โจทย์ ปรนัย
How do regulatory bodies like the FDA and EMA ensure the safety of CGT products?

The article explicitly stated that regulatory bodies ensure CGT product safety through mandatory, rigorous clinical testing before approval, not through advertising oversight, social media, or direct sales.

Approved and Proven CGT Products: "CGT products must undergo a rigorous process of quality, safety and efficacy demonstration under the oversight of regulatory agencies... Substantial evidence of safety and efficacy is typically required before marketing approval." Levels of Evidence Required for Widespread Approval: "The gold standard is well-designed, strictly supervised clinical research studies... preferably randomized and controlled."

โจทย์ ปรนัย
What is the primary goal of the ISCT's position on cell and gene therapies as mentioned in the article?

The article stated that ISCT's primary mission is to advocate for scientifically validated therapies while combating premature commercialization of unproven treatments, with patient safety as the guiding principle.

Abstract: "The International Society for Cell & Gene Therapy... has opposed the premature commercialization of unproven cell- and gene-based interventions and supported the development of evidence-based advanced therapy products." Introduction: "ISCT has played an important role in opposing the premature commercialization... and supporting the development of evidence-based, safe, and efficacious advanced medicinal products." Conclusions: "This document reflects ISCT's commitment to promoting patient safety... by helping members identify 'red flags' associated with concerning practices and understand the importance of robust clinical research."

โจทย์ ปรนัย
What is a potential consequence for patients using unproven CGT products?

The article explicitly warned that unproven CGT products carry significant health risks, including severe physical harm due to their untested nature and lack of regulatory oversight.

Approved and Proven CGT Products: "Many of these products and their administration have been shown to result in adverse physical effects, from blindness to infections or even death, and considerable financial and psychological harm." Features of Unproven Interventions: "These interventions are potentially unsafe and there is little or no evidence to support claims that they will have meaningful therapeutic effects."

โจทย์ ปรนัย
What role does the ISCT play in the context of cell and gene therapies?

The article clearly stated that ISCT's primary role is to advocate against unproven CGTs while supporting evidence-based development, not to fund research, regulate products, or sell therapies.

Abstract: "The International Society for Cell & Gene Therapy... has opposed the premature commercialization of unproven cell- and gene-based interventions and supported the development of evidence-based advanced therapy products." Introduction: "ISCT has played an important role in opposing the premature commercialization... and supporting the development of evidence-based, safe, and efficacious advanced medicinal products." Conclusions: "This document reflects ISCT's commitment to... helping members identify 'red flags' associated with concerning practices."